These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26444605)

  • 1. Association of whole blood viscosity with non-alcoholic fatty liver disease.
    Yu XY; Li Y; Liu T; Wang RT
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):335-43. PubMed ID: 26444605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease.
    Yu KJ; Zhang MJ; Li Y; Wang RT
    J Gastroenterol Hepatol; 2014 Mar; 29(3):540-4. PubMed ID: 23981121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated whole blood viscosity is associated with insulin resistance and non-alcoholic fatty liver.
    Zhao HY; Li J; Xu M; Wang TG; Sun WW; Chen Y; Bi YF; Wang WQ; Ning G
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):806-11. PubMed ID: 25823525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population.
    Hung WC; Wu JS; Sun ZJ; Lu FH; Yang YC; Chang CJ
    BMJ Open; 2016 Nov; 6(11):e013106. PubMed ID: 27852719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between whole blood viscosity and arterial stiffness in patients with type 2 diabetes mellitus.
    Li Y; Tian XX; Liu T; Wang RT
    Endocrine; 2015 May; 49(1):148-54. PubMed ID: 25312690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
    Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
    Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
    Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased whole blood viscosity is associated with silent cerebral infarction.
    Li RY; Cao ZG; Li Y; Wang RT
    Clin Hemorheol Microcirc; 2015; 59(4):301-7. PubMed ID: 23988733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.
    El Hadi H; Di Vincenzo A; Vettor R; Rossato M
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).
    Zhai HL; Wang NJ; Han B; Li Q; Chen Y; Zhu CF; Chen YC; Xia FZ; Cang Z; Zhu CX; Lu M; Lu YL
    Br J Nutr; 2016 Apr; 115(8):1352-9. PubMed ID: 26888280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-blood viscosity increases significantly in small arteries and capillaries in hemodiafiltration. Does acute hemorheological change trigger cardiovascular risk events in hemodialysis patient?
    Canaud B; Rodriguez A; Chenine L; Morena M; Jaussent I; Leray-Moragues H; Picard A; Cristol JP
    Hemodial Int; 2010 Oct; 14(4):433-40. PubMed ID: 20955276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.